PI: Franch Nadal, Josep. A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients who Initiated Exenatide as Compared with those who Initiated Other non-Glucagon-Like Peptide 1 Receptor Agonists based Glucose Lowering Drugs (EXCEED). Funding: IQVIA LTD. Duration: 2020 - 2024

PI: Mauricio Puente, Dídac. International diabetes federation diabetes atlas data from Catalonian population database. Funding: ICS - Institut Català de la Salut. Duration: 2021 - 2023

PI: Vidal Alaball, Josep. L'impacte indirecte de la pandèmia: determinants i conseqüències de l'accés als serveis públics de salut durant la pandèmia de COVID-19. Funding: IDIAP Jordi Gol. Duration: 2021 - 2023

PI: Franch Nadal, Josep. A Real-World Database Study of Canagliflozin Utilization in Type 1 Diabetes Patients Over Time among European Countries. Funding: Janssen Research & Development, LLC. Duration: 2021 - 2023

PI: Mata Cases, José Manuel. Evolución de control metabólico de la diabetes tipo 2 en atención primaria de Cataluña. Funding: ICS - Institut Català de la Salut. Duration: 2021 - 2023

PI: Franch Nadal, Josep. Gestational diabetes and complications among pregnant women attended in primary care sexual and reproductive health services in Catalonia. Funding: . Duration: 2021 - 2023

PI: Franch Nadal, Josep. Impacto de la diabetes y la obesidad en la infección por SARS-CoV-2: Identificación de factores pronóstico y creación de un score predictivo basado en técnicas de inteligencia artificial. Funding: IDIAP Jordi Gol. Duration: 2021 - 2023

PI: Franch Nadal, Josep. ContRol de la diabEteS tipo 2 En tIempoS de pandemia COVID-19 en centros de aTención primaria. Estudio RESIST. Funding: Redgedaps, s.l.. Duration: 2021 - 2022

PI: Soldevila Madorell, Berta. Epidemiologia de diabetis gestacional i d'alteracions glucèmiques en el postpart a Catalunya. Estudi epiDMGCAT. Funding: IDIAP Jordi Gol. Duration: 2020 - 2022

PI: Mauricio Puente, Dídac. Epidemiología de SARS-CoV-2 en personas con obesidad y/o diabetes mellitus en Cataluña - Estudio epiCOVID19DMO. Funding: IDIAP Jordi Gol. Duration: 2020 - 2022

PI: Ortega Martínez de Victoria, Emilio. Epidemiología de la hipertrigliceridemia grave y su relación con la incidencia de pancreatitis aguda y enfermedad cardiovascular en Cataluña. Funding: IDIAP Jordi Gol. Duration: 2020 - 2022

PI: Franch Nadal, Josep. Relación entre la retinopatía diabética y el descenso rápido de la HbA1c en pacientes con diabetes mellitus tipo 2: estudio de casos y controles con la base de datos SIDIAP. Funding: Novo Nordisk Pharma, S.A.. Duration: 2021 - 2021

PI: IP no primaria. Estudi del perfil i cinètica longitudinal dels anticossos al personal sanitari de la Catalunya Central infectat per SARS-CoV-2 (SERO CATCentral). Funding: ICS - Institut Català de la Salut. Duration: 2020 - 2021

PI: Franch Nadal, Josep. TrAtamiento Relacionado con Guias para el ? paciEnTe con DM2. Estudio TARGET. Funding: ICS - Institut Català de la Salut. Duration: 2020 - 2021

PI: Ortega Martínez de Victoria, Emilio. Impacto de la obesidad y/o la diabetes mellitus en personas hospitalizadas por COVID19. Funding: ICS - Institut Català de la Salut. Duration: 2020 - 2021

PI: Bundo Vidiella, Magdalena. Estudio transversal para analizar la epidemiología del pie diabético en los pacientes con diabetes mellitus tipo 2 con la base de datos SIDIAP. Funding: ICS - Institut Català de la Salut. Duration: 2019 - 2021

PI: Canivell Fusté, Silvia. Caracterización del riesgo fracturario en pacientes diabéticos mayores de 50 años tratados con SGLT2 inhibidores. Funding: ICS - Institut Català de la Salut. Duration: 2019 - 2021

PI: Mauricio Puente, Dídac. All-cause and cardio-renal-metabolic mortality in people with type 2 diabetes: a comparative international trend study.. Funding: University of Leicester. Duration: 2019 - 2021

PI: Mauricio Puente, Dídac. Descubrimiento y validación de marcadores de predicción de diabetes tipo 2: proyecto colaborativo de cohortes.. Funding: IDIAP Jordi Gol. Duration: 2019 - 2021

PI: Canivell Fusté, Silvia. Influencia del tratamiento antidiabético en el desarrollo de deterioro cognitivo en los pacientes diabéticos tipo 2 en Barcelona. Funding: ICS - Institut Català de la Salut. Duration: 2019 - 2021

PI: Rovira Algara, Carol. ASSAIG CLÍNIC MULTICÈNTRIC ALEATORITZAT OBERT PER AVALUAR L? IMPACTE DE LA INTERVENCIÓ DE MILLORA DE L? ADEQUACIÓ EN L? ÚS DE MEDICAMENTS DELS PACIENTS POLIMEDICATS SEGONS EL MODEL D? ATENCIÓ CENTRADA EN LA PERSONA PER UN EQUIP MULTIDISCIPLINAR A L?ATENCIÓ PRIMÀRIA DEL BAGES. Funding: ICS - Institut Català de la Salut. Duration: 2019 - 2021

PI: IP no primaria. Estudio de intervención longitudinal prospectivo sobre enfermedades vasculares y renales ocultas de la cohorte ILERVAS en la provincia de Lleida. ILERVAS PLUS. El bus de la salut. Funding: ICS - Institut Català de la Salut. Duration: 2019 - 2021

Alonso SP, Valdés S, Maldonado-Araque C, Lago A, Ocon P, Calle A, Castaño L, Delgado E, Menéndez E, Franch-Nadal J, Gaztambide S, Girbés J, Chaves F, García-Serrano S, García-Escobar E, Fernández-García JC, Olveira G, Colomo N, Rojo-Martínez G. Thyroid hormone resistance index and mortality in euthyroid subjects: Di@bet.es study. Eur J Endocrinol. 2021 Nov; doi:10.1530/EJE-21-0640. Epub 2021 Nov 01. PMID:34735370. IF: 6,664.

Antonio-Arques V, Franch-Nadal J, Caylà JA. Diabetes and tuberculosis: a syndemic complicated by COVID-19. Med Clin (Barc). 2021 Sep; 157(6):288-293. doi:10.1016/j.medcli.2021.04.004. Epub 2021 May 06. pmc:PMC8101986. PMID:34049681. IF: 1,725.

Antonio-Arques V, Franch-Nadal J, Caylà JA. Diabetes and tuberculosis: A syndemic complicated by COVID-19. Med Clin (Engl Ed). 2021 Sep; 157(6):288-293. doi:10.1016/j.medcle.2021.04.006. Epub 2021 Sep 11. pmc:PMC8433042. PMID:34541325. IF: .

Arroyo-Díaz JA, Julve J, Vlacho B, Corcoy R, Ponte P, Román E, Navas-Méndez E, Llauradó G, Franch-Nadal J, Domingo P, Mauricio D. Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study. Front Public Health. 2021 ; 9:758347. doi:10.3389/fpubh.2021.758347. Epub 2021 Sep 24. pmc:PMC8498099. PMID:34631653. IF: .

Bundó M, Llussà J, Serra M, la Iglesia PP, Gimbert RM, Real J, Vlacho B, Mata-Cases M, Cos X, Franch-Nadal J, Mauricio D. Incidence and characteristics of diabetic foot ulcers in subjects with type 2 diabetes in Catalonian primary care centres: An observational multicentre study. Prim Care Diabetes. 2021 Aug; doi:10.1016/j.pcd.2021.08.002. Epub 2021 Aug 18. PMID:34419365. IF: 2,459.

Castelblanco E, Hernández M, Ortega E, Amigó N, Real J, Granado-Casas M, Miñambres I, López C, Lecube A, Bermúdez-López M, Alonso N, Julve J, Mauricio D. Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control. Diabetes Res Clin Pract. 2021 Dec; 182:109145. doi:10.1016/j.diabres.2021.109145. Epub 2021 Nov 13. PMID:34785302. IF: 5,602.

Castelblanco E, Sarrias MR, Betriu À, Soldevila B, Barranco-Altirriba M, Franch-Nadal J, Valdivielso JM, Bermudez-Lopez M, Groop PH, Fernández E, Alonso N, Mauricio D. Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease. Aging (Albany NY). 2021 10; 13(19):22690-22709. doi:10.18632/aging.203615. Epub 2021 Oct 10. pmc:PMC8544330. PMID:34629330. IF: .

Cea-Soriano L, Pulido J, Franch-Nadal J, Santos JM, Mata-Cases M, Díez-Espino J, Ruiz-García A, Regidor E; PREDAPS Study Group. Mediterranean diet and diabetes risk in a cohort study of individuals with prediabetes: propensity score analyses. Diabet Med. 2021 Dec; doi:10.1111/dme.14768. Epub 2021 Dec 11. PMID:34897805. IF: 4,359.

Dobaño C, Jiménez A, Rubio R, Alonso S, Ramírez-Morros A, Vidal M, Vidal-Alaball J, Ruiz-Comellas A, García-Basteiro AL, Izquierdo L, Aguilar R, Moncunill G. Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen. Transl Res. 2021 Oct; doi:10.1016/j.trsl.2021.10.004. Epub 2021 Oct 25. pmc:PMC8546430. PMID:34710636. IF: 7,012.

Dobaño C, Ramírez-Morros A, Alonso S, Vidal-Alaball J, Ruiz-Olalla G, Vidal M, Rubio R, Cascant E, Parras D, Rodrigo Melero N, Serra P, Carolis C, Santamaria P, Forcada A, Mendioroz J, Aguilar R, Moncunill G, Ruiz-Comellas A. Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19. BMC Med. 2021 06; 19(1):155. doi:10.1186/s12916-021-02032-2. Epub 2021 Jun 28. pmc:PMC8237770. PMID:34183003. IF: 8,775.

Dòria M, Betriu À, Belart M, Rosado V, Hernández M, Sarro F, Real J, Castelblanco E, Pacheco LR, Fernández E, Franch-Nadal J, Gratacòs M, Mauricio D. High Incidence of Adverse Outcomes in Haemodialysis Patients with Diabetes with or without Diabetic Foot Syndrome: A 5-Year Observational Study in Lleida, Spain. J Clin Med. 2021 Mar; 10(7). doi:10.3390/jcm10071368. Epub 2021 Mar 26. pmc:PMC8037880. PMID:33810545. IF: 3,303.

Falguera M, Castelblanco E, Rojo-López MI, Vilanova MB, Real J, Alcubierre N, Miró N, Molló À, Mata-Cases M, Franch-Nadal J, Granado-Casas M, Mauricio D. Mediterranean Diet and Healthy Eating in Subjects with Prediabetes from the Mollerussa Prospective Observational Cohort Study. Nutrients. 2021 Jan; 13(1). doi:10.3390/nu13010252. Epub 2021 Jan 16. pmc:PMC7830064. PMID:33467197. IF: 5,717.

Franch-Nadal J, Fornos JA, Melogno Klinkas M, Rodríguez de Miguel M, Rodríguez-Fortúnez P, Lizán L, de Paz HD, Lería Gelabert M. Management of prediabetes from the perspective of Spanish physicians and community pharmacists: Detecta2 study. Endocrinol Diabetes Nutr (Engl Ed). 2021 May; doi:10.1016/j.endinu.2020.12.007. Epub 2021 May 17. PMID:34016564. IF: 1,417.

Franch-Nadal J, Real J, Mata-Cases M, Ortega E, Antoni Vallès J, Vlacho B, Mauricio D. Compliance with the DPP-4 inhibitors dose adjustment recommendations based on renal function in a population database. Endocrinol Diabetes Nutr (Engl Ed). 2021 Jun; doi:10.1016/j.endinu.2021.01.013. Epub 2021 Jun 01. PMID:34088634. IF: 1,417.

Garcia-Moll X, Barrios V, Franch-Nadal J. Moving from the stratification of primary and secondary prevention of cardiovascular risk in diabetes towards a continuum of risk: need for a new paradigm. Drugs Context. 2021 ; 10. doi:10.7573/dic.2021-6-3. Epub 2021 Aug 18. pmc:PMC8378315. PMID:34466139. IF: .

Gimenez-Perez G, Franch-Nadal J, Ortega E, Mata-Cases M, Goday A, Real J, Rodriguez A, Vlacho B, Mauricio D. Clinical Characteristics and Degree of Glycemic and Cardiovascular Risk Factor Control in Patients with Type 1 Diabetes in Catalonia (Spain). J Clin Med. 2021 Apr; 10(7). doi:10.3390/jcm10071536. Epub 2021 Apr 06. pmc:PMC8038775. PMID:33917523. IF: 3,303.

Giráldez-García C, Cea-Soriano L, Albaladejo R, Franch-Nadal J, Mata-Cases M, Díez-Espino J, Artola S, Serrano R, Regidor E; PREDAPS Study Group. The heterogeneity of reversion to normoglycemia according to prediabetes type is not explained by lifestyle factors. Sci Rep. 2021 May; 11(1):9667. doi:10.1038/s41598-021-87838-z. Epub 2021 May 06. pmc:PMC8102601. PMID:33958606. IF: 4,379.

González Tejón S, Ibarra Jato M, Fernández San Martín MI, Prats Uribe A, Real Gatius J, Martin-Lopez LM. [Hip fractures in patients treated with antipsychotic drugs. Study of retrospective cohorts in Catalonia]. Aten Primaria. 2021 Nov; 54(2):102171. doi:10.1016/j.aprim.2021.102171. Epub 2021 Nov 16. Spanish. pmc:PMC8605286. PMID:34798403. IF: 1,137.

Julián MT, Pera G, Soldevila B, Caballería L, Julve J, Puig-Jové C, Morillas R, Torán P, Expósito C, Puig-Domingo M, Castelblanco E, Franch-Nadal J, Cusi K, Mauricio D, Alonso N. Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study. Eur J Endocrinol. 2021 Apr; 184(4):587-596. doi:10.1530/EJE-20-1240. PMID:33606661. IF: 6,664.

Lopez Segui F, Hernandez Guillamet G, Pifarré Arolas H, Marin-Gomez FX, Ruiz Comellas A, Ramirez Morros AM, Adroher Mas C, Vidal-Alaball J. Characterization and Identification of Variations in Types of Primary Care Visits Before and During the COVID-19 Pandemic in Catalonia: Big Data Analysis Study. J Med Internet Res. 2021 09; 23(9):e29622. doi:10.2196/29622. Epub 2021 Sep 14. PMID:34313600. IF: 5,428.

Maldonado-Araque C, Valdés S, Badía-Guillén R, Lago-Sampedro A, Colomo N, Garcia-Fuentes E, Gutierrez-Repiso C, Goday A, Calle-Pascual A, Castaño L, Castell C, Delgado E, Menendez E, Franch-Nadal J, Gaztambide S, Girbés J, Chaves FJ, Soriguer F, Rojo-Martínez G. Iodine Deficiency and Mortality in Spanish Adults: Di@bet.es Study. Thyroid. 2021 01; 31(1):106-114. doi:10.1089/thy.2020.0131. Epub 2020 Sep 17. pmc:PMC7840306. PMID:32781944. IF: 6,568.

Mas-Alòs S, Planas-Anzano A, Peirau-Terés X, Real-Gatius J, Galindo-Ortego G. Feasibility Assessment of the Let's Walk Programme (CAMINEM): Exercise Training and Health Promotion in Primary Health-Care Settings. Int J Environ Res Public Health. 2021 03; 18(6). doi:10.3390/ijerph18063192. Epub 2021 Mar 19. pmc:PMC8003347. PMID:33808729. IF: 2,849.

Mata-Cases M, Franch-Nadal J, Real J, Vlacho B, Gómez-García A, Mauricio D. Evaluation of clinical and antidiabetic treatment characteristics of different sub-groups of patients with type 2 diabetes: Data from a Mediterranean population database. Prim Care Diabetes. 2021 06; 15(3):588-595. doi:10.1016/j.pcd.2021.02.003. Epub 2021 Feb 16. PMID:33602606. IF: 2,459.

Mata-Cases M, Vlacho B, Real J, Puig-Treserra R, Bundó M, Franch-Nadal J, Mauricio D. Trends in the Degree of Control and Treatment of Cardiovascular Risk Factors in People With Type 2 Diabetes in a Primary Care Setting in Catalonia During 2007-2018. Front Endocrinol (Lausanne). 2021 ; 12:810757. doi:10.3389/fendo.2021.810757. Epub 2022 Jan 10. pmc:PMC8784522. PMID:35082758. IF: 5,555.

Mauricio D, Vlacho B, Barrot de la Puente J, Mundet-Tudurí X, Real J, Kulisevsky J, Ortega E, Castelblanco E, Julve J, Franch-Nadal J. Associations Between Diabetic Retinopathy and Parkinson's Disease: Results From the Catalonian Primary Care Cohort Study. Front Med (Lausanne). 2021 ; 8:800973. doi:10.3389/fmed.2021.800973. Epub 2022 Jan 18. pmc:PMC8804230. PMID:35118094. IF: 5,093.

Obaya Rebollar JC, Miravet Jiménez S, Aranbarri Osoro I, Carramiñana Barrera FC, García Soidán FJ, Cebrián Cuenca AM. [Management of patient profiles with type2 diabetes mellitus in Primary Care in Spain: CONTROVERTI2 Program]. Semergen. 2021 Aug; doi:10.1016/j.semerg.2021.07.009. Epub 2021 Aug 24. Spanish. PMID:34452834. IF: .

Ortega E, Corcoy R, Gratacòs M, Cos Claramunt FX, Mata-Cases M, Puig-Treserra R, Real J, Vlacho B, Castelblanco E, Domingo P, Khunti K, Franch-Nadal J, Mauricio D. Risk factors for severe outcomes in people with diabetes hospitalised for COVID-19: a cross-sectional database study. BMJ Open. 2021 07; 11(7):e051237. doi:10.1136/bmjopen-2021-051237. Epub 2021 Jul 22. pmc:PMC8300551. PMID:34301668. IF: 2,692.

Puig-Jové C, Castelblanco E, Falguera M, Hernández M, Soldevila B, Julián MT, Teis A, Julve J, Barranco-Altirriba M, Franch-Nadal J, Puig-Domingo M, Ortega E, Amigó N, Alonso N, Mauricio D. Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism. Rev Esp Cardiol (Engl Ed). 2021 Mar; doi:10.1016/j.rec.2021.02.006. Epub 2021 Mar 27. PMID:33785266. IF: .

Real J, Vlacho B, Ortega E, Vallés JA, Mata-Cases M, Castelblanco E, Wittbrodt ET, Fenici P, Kosiborod M, Mauricio D, Franch-Nadal J. Cardiovascular and mortality benefits of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia. Cardiovasc Diabetol. 2021 Jul; 20(1):139. doi:10.1186/s12933-021-01323-5. Epub 2021 Jul 09. pmc:PMC8272340. PMID:34243779. IF: 7,332.

Regidor E, Cea-Soriano L, Ruiz A, Goday A, Carabantes D, Díez-Espino J, Artola S, Franch-Nadal J; PREDAPS Study Group. Classifying and communicating risks in prediabetes according to fasting glucose and/or glycated hemoglobin: PREDAPS cohort study. Scand J Prim Health Care. 2021 Aug; doi:10.1080/02813432.2021.1958497. Epub 2021 Aug 04. PMID:34348071. IF: 2,581.

Rojo-López MI, Castelblanco E, Real J, Hernández M, Falguera M, Amigó N, Julve J, Alonso N, Franch-Nadal J, Granado-Casas M, Mauricio D. Advanced Quantitative Lipoprotein Characteristics Do Not Relate to Healthy Dietary Patterns in Adults from a Mediterranean Area. Nutrients. 2021 Dec; 13(12). doi:10.3390/nu13124369. Epub 2021 Dec 06. pmc:PMC8706087. PMID:34959921. IF: 5,717.

Romero-Aroca P, Verges-Pujol R, Santos-Blanco E, Maarof N, Valls A, Mundet X, Moreno A, Galindo L, Baget-Bernaldiz M. Validation of a Diagnostic Support System for Diabetic Retinopathy Based on Clinical Parameters. Transl Vis Sci Technol. 2021 03; 10(3):17. doi:10.1167/tvst.10.3.17. pmc:PMC7980045. PMID:34003951. IF: 2,112.

Ruiz-Comellas A, Pera G, Baena-Díez JM, Mundet Tudurí X, Heras A, Forés-Raurell R, Torán-Montserrat P, Alzamora-Sas MT. [Relationship between physical activity during leisure time and progression of ankle-brachial index]. Gac Sanit. 2021 Aug; doi:10.1016/j.gaceta.2021.06.006. Epub 2021 Aug 17. Spanish. PMID:34417057. IF: 2,139.

Ruiz-Comellas A, Sauch Valmaña G, Mendioroz Peña J, Roura Poch P, Sabata Carrera A, Cornet Pujol I, Gómez Baena I, Casaldàliga Solà À, Saldaña Vila C, Fusté Gamisans M, Boix De la Casa C, Rodoreda Pallàs B, Ramirez-Morros A, Vazquez Abanades L, Vidal-Alaball J. Physical activity, emotional state and socialization in the elderly: study protocol for a clinical multicentre randomized trial. J Int Med Res. 2021 Jun; 49(6):3000605211016735. doi:10.1177/03000605211016735. pmc:PMC8236794. PMID:34154431. IF: 1,671.

Seidu S, Cos X, Brunton S, Harris SB, Jansson SPO, Mata-Cases M, Neijens AMJ, Topsever P, Khunti K. A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe. Prim Care Diabetes. 2021 02; 15(1):31-51. doi:10.1016/j.pcd.2020.05.004. Epub 2020 Jun 10. PMID:32532635. IF: 2,459.

Teis A, Castelblanco E, Cediel G, Amigó N, Julve J, Ribalta J, Guardiola M, Franch J, Bermúdez-López M, Codina P, Lupón J, Mauricio D, Alonso N, Bayés-Genís A. H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls. Rev Esp Cardiol (Engl Ed). 2021 Oct; doi:10.1016/j.rec.2021.09.008. Epub 2021 Oct 26. PMID:34716123. IF: .

Vlacho B, Mata-Cases M, Mundet-Tudurí X, Vallès-Callol JA, Real J, Farre M, Cos X, Khunti K, Mauricio D, Franch-Nadal J. Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area: A Retrospective Cohort Study. Front Endocrinol (Lausanne). 2021 ; 12:708372. doi:10.3389/fendo.2021.708372. Epub 2021 Jul 14. pmc:PMC8318034. PMID:34335477. IF: 5,555.

Vlacho B, Mata-Cases M, Mundet-Tudurí X, Vallès-Callol JA, Real J, Farre M, Cos X, Khunti K, Mauricio D, Franch-Nadal J. Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area: A Retrospective Cohort Study. Front Endocrinol (Lausanne). 2021 Jul 14;12:708372. doi: 10.3389/fendo.2021.708372. PMID: 34335477; PMCID: PMC8318034. IF: 5,555.

Researchers with PhD

8

Total number of projects in which group members have participated

22

Total number of projects in which the PI of the project has belonged to the group

14

Total Funding

519.688 €

Scientific publications in indexed journals

31

Total Impact factor

129,7

Nº of articles in Q1 journals

13

Q1 IF

79,191

Nº of articles in Q2 journals

3

Q2 IF

9,632